Insulet Corp (FRA:GOV)
€ 250.4 24.9 (11.04%) Market Cap: 17.41 Bil Enterprise Value: 17.87 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 90/100

Insulet Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 10, 2021 / 05:15PM GMT
Release Date Price: €248.8 (-3.15%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst

Good afternoon, and thank you for joining us for the second day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the healthcare research team here at Morgan Stanley.

It's my pleasure to have Insulet with us today, Shacey Petrovic, President and CEO; and Deb Gordon, Vice President, IR.

Before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

And with that, Shacey, Deb, thank you for joining us today.

Shacey Petrovic
Insulet Corporation - President, CEO & Director

Thanks, Cecilia. Great to be here with you.

Deborah R. Gordon
Insulet Corporation - VP of IR

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot